FDA’s newly proposed rule requiring food companies to disclose safety information about ingredients they determine are safe is already raising concerns among longtime regulatory attorneys and consumer ...

Senate health committee Chair Bill Cassidy (R-LA) wants to “expand TrumpRx” as part of broader health care agenda he unveiled Wednesday (April 15) that aims to improve price transparency, further rein ...

Sen. Elizabeth Warren (D-MA) is questioning whether the Trump administration reliably estimate the amount of money saved through the TrumpRx platform after HHS Secretary Robert F. Kennedy Jr. said in ...

CMS should give states the flexibility to adjust their Rural Health Transformation Program plans as needed by shortening or making flexible the five-year rural service commitment required for ...

The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...

As key Senate Democrats seek input on ways to design a public insurance option to cut health care costs, some prominent health care experts suggest a better way to improve federal health care ...

Medical associations are reiterating their recommendations that all adults and children over a certain age receive vaccinations against COVID-19, influenza and respiratory syncytial virus (RSV), which ...

FDA’s staffing numbers are continuing to decrease in fiscal 2026 despite promises from HHS Secretary Robert F. Kennedy Jr. to prioritize hiring, a problem President Donald Trump’s new commissioner ...

With uncertainty surrounding the future of vaccine policy after President Donald Trump’s latest executive order, one stakeholder organization is urging the White House and HHS to commission an ...

States suing over the Medicaid work requirements interim final rule are narrowing their challenges to focus on alleged violations of the Administrative Procedure Act like the medically frail exemption ...

The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...

Amid Eli Lilly’s expanding legal fight with compounders and online peptide sellers marketing its experimental weight-loss drug retatrutide, FDA has sent another tranche of warning letters to five ...